• Explore /
  • Poster
  • / Gene-by-gene analysis in the MAGNITUDE study of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations.

Gene-by-gene analysis in the MAGNITUDE study of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations.

Abstract Video & Slides Poster

Authors

null

Shahneen Sandhu

Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia

Shahneen Sandhu , Gerhardt Attard , David Olmos , Eleni Efstathiou , Elena Castro , Dana E. Rathkopf , Matthew Raymond Smith , Guilhem Roubaud , Eric Jay Small , Andrea Juliana Gomes , Marniza Saad , Deniz Tural , Shibu Thomas , Karen Urtishak , Michael Gormley , Gary Mason , Brooke Diorio , George C. Wang , Angela Lopez-Gitlitz , Kim N. Chi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

NCT03748641

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5020)

DOI

10.1200/JCO.2022.40.16_suppl.5020

Abstract #

5020

Poster Bd #

204

Abstract Disclosures

Similar Posters

First Author: Vivek Narayan

First Author: Daniel Triner

First Author: Laura Graham

First Author: Dong Shen